Nuvexa Biologix

Co-Owned by OmniMedix AVR

Nuvexa Biologix offers high-quality, premium biologic solutions tailored to the unique needs of modern medical practices. Co-owned by OmniMedix AVR, we’re more than just a supplier—we’re a partner in helping you integrate these advanced therapies into your clinic with confidence.

From product selection and education to dosing support and clinical application, our team is here to assist every step of the way. We simplify the process, provide guidance, and ensure you have everything needed to deliver exceptional patient outcomes through biologic therapy.

At OmniMedix AVR, our commitment to personalized service goes beyond fulfillment—we provide direct access to experienced MDs who are available to consult with our clients on protocols, dosing, and clinical strategy. This level of support ensures our partners can make confident, informed decisions when incorporating new therapies into their practice.

Our agility and responsiveness allow us to stay ahead of the curve in a rapidly evolving industry. We continually adapt our offerings and services to meet the real-world needs of providers—whether that’s streamlining logistics, sourcing high-quality biologics, or developing custom solutions for patient care.

Open, transparent communication is at the core of everything we do. From initial onboarding through ongoing support, we ensure our clients are kept informed and empowered. When you partner with OmniMedix AVR, you gain more than a supplier—you gain a clinically aligned, collaborative team focused on your success and your patients’ outcomes.

Products

  • Nuvexa 180

    Double-Concentration Cord Blood-Derived Exosomes | hPESC-Based | Peer-Reviewed Potency and Purity

    Nuvexa 180 offers the same advanced formulation as Nuvexa 90—now with double the concentration of biologically active exosomes per vial. Sourced from cord blood-derived human progenitor endothelial stem cells (hPESCs), this high-impact regenerative product is validated using ELISA, nanoparticle tracking analysis, and single particle interferometric reflectance imaging sensing.

    Nuvexa 180 is engineered to drive fibroblast proliferation, stimulate stem cell migration, and optimize tissue regeneration for a wide range of aesthetic and therapeutic applications.

    Each vial contains a robust matrix of growth factors and cytokines, including:

    • IGFBP 1, 2, 3, 6

    • Insulin

    • Growth Hormone

    • PDGF-AA

    • TGF-β1

    • VEGF

    • IL-1RA (anti-inflammatory)

    Membrane-enclosed exosome particles within the expected size range and expressing CD81 and CD9 tetraspanins confirm both identity and purity. Backed by published peer-reviewed research, Nuvexa 180 offers an exceptional option for providers seeking maximum potency with proven quality.

  • Nuvexa 100

    100 Billion Exosomes | MSC Wharton’s Jelly-Derived Formulation | Potent, Ready-to-Use | Transparent Product Contents

    Advanced Regeneration Without the Wait

    Nuvexa 100 delivers double the concentration of our Nuvexa 50 formulation, featuring 100 billion reconstituted exosomes derived from Wharton’s Jelly mesenchymal stem cells. Rich in powerful growth factors—Placental, Vascular Endothelial, and Transforming Growth Factors (TGF)—this acellular, next-gen biologic is designed for providers seeking immediate-use potency with broad clinical application.

    Ready-to-Use Potency. No Reconstitution. No Compromise.

    Unlike lyophilized formats, Nuvexa 100 is pre-reconstituted and ready for immediate use, saving time and simplifying integration into advanced treatment protocols. This formulation maintains the same purity, peptide integrity, and regenerative potential—now in a convenient liquid form.

    Transparent Quality, Clinical Confidence

    As with all Nuvexa products, full ingredient transparency and clear glass packaging reflect our commitment to provider trust and product integrity. With Nuvexa 100, you’re not just getting unmatched potency—you’re giving your patients results they can feel, and outcomes you can confidently stand behind.

  • Nuvexa 90

    Cord Blood-Derived Exosomes | hPESC-Based | Potency Backed by Peer-Reviewed Research

    Introducing Nuvexa 90—a breakthrough in regenerative science, crafted from cord blood-derived exosomes and developed for providers seeking advanced, research-supported biologic solutions. Derived from human progenitor endothelial stem cells (hPESCs), Nuvexa 90 is rich in biologically active components and validated through advanced techniques including ELISA, nanoparticle tracking analysis, and interferometric reflectance imaging sensing.

    This formulation is designed to promote fibroblast proliferation, encourage stem cell migration, and support tissue repair—making it highly effective for a wide range of aesthetic and regenerative protocols.

    Nuvexa 90 features a complex profile of potent growth factors, including:

    • IGFBP 1, 2, 3, 6

    • Insulin

    • Growth Hormone

    • PDGF-AA

    • TGF-β1

    • VEGF

    • IL-1RA (an anti-inflammatory cytokine)

    Exosome-size membrane-enclosed particles expressing CD81 and CD9 tetraspanins confirm the product’s integrity and exosomal purity. With published peer-reviewed data supporting both process and performance, Nuvexa 90 is a trusted, high-potency solution for next-generation regenerative care.

  • Nuvexa 50

    50 Billion Lyophilized Exosomes | MSC Wharton’s Jelly-Derived Formulation | Potency and Transparent Product Contents

    Discover the Science Behind Nuvexa 50

    Nuvexa 50 represents the next generation of regenerative biologics, developed through rigorous research and a commitment to clinical excellence. This advanced formulation begins with umbilical cord-derived exosomes—rich in potent growth factors including Placental, Vascular Endothelial, and Transforming Growth Factors (TGF). The result is a unique, acellular biologic that delivers unmatched versatility and efficacy across a wide range of applications.

    Nuvexa 50: Where Convenience Meets Clinical Potency

    Nuvexa 50 is shelf-stable and requires no refrigeration, offering maximum flexibility without compromising purity. Our proprietary lyophilization process preserves essential peptides, proteins, and growth factors by gently dehydrating them—ensuring the product retains its full regenerative power. This makes it easy to integrate into any clinical workflow based on your patient’s specific needs.

    Transparency and Trust in Every Vial

    We believe providers deserve full visibility into what they’re using. That’s why Nuvexa 50 is packaged in transparent glass vials, with all ingredients clearly disclosed. This level of transparency reflects our unwavering commitment to quality, trust, and results. When you choose Nuvexa 50, you're not only offering your patients an exceptional product—you're delivering outcomes they can truly feel.

  • Nuvexa 30

    30 Billion Lyophilized Exosomes | Enhanced with Peptides & Growth Factors | Transparent, Shelf-Stable Formula

    Nuvexa 30 combines science and aesthetics to deliver advanced cosmetic support using 30 billion umbilical cord-derived exosomes. Each vial contains a potent blend of Placental, Vascular Endothelial, and Transforming Growth Factors, enhanced with essential peptides to support collagen production and skin rejuvenation.

    Our lyophilization process ensures shelf stability without refrigeration, preserving purity and potency for daily use in aesthetic protocols. With fully disclosed ingredients and transparent packaging, Nuvexa 30 sets a new standard for visible results and clinical confidence.

NAD+ Infusion Therapy

A Complete Clinical Guide for Providers—your resource for science-backed protocols, dosing, and strategies to boost vitality, cognition, and recovery.